Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Teijin announced it will return the manufacturing and sales rights for two pharmaceutical products to their licensors in January 2027 upon expiry of the license period, transferring Mucosolvan to Nippon Chemiphar and Laxoberon oral solution 0.75% to another licensor.30d agoTeijin and Asahi Kasei will launch a joint textile trading company, TA Frontier, on October 1, integrating their textile trading subsidiaries.31d ago